UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 146

Sortiert nach

Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality

Thrombosis and haemostasis, 2007-10, Vol.98 (4), p.756

2007

Link zum Volltext

Verfügbarkeit prüfen

The mechanism of action of rivaroxaban – an oral, direct Factor Xa inhibitor – compared with other anticoagulants

Thrombosis research, 2011-06, Vol.127 (6), p.497-504

Samama, Meyer Michel

2011

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the pharmacological properties and clinical results of the synthetic pentasaccharide (fondaparinux)

Thrombosis Research, 2003, Vol.109 (1), p.1-11

2003

Link zum Volltext

Verfügbarkeit prüfen

Monitoring plasma levels of factor Xa inhibitors: how, why and when?

Expert Review of Hematology, 2013-04, Vol.6 (2), p.155-164

2013

Link zum Volltext

Verfügbarkeit prüfen

Assessment of laboratory assays to measure rivaroxaban--an oral, direct factor Xa inhibitor

Thrombosis and haemostasis, 2010-04, Vol.103 (4), p.815

2010

Link zum Volltext

Verfügbarkeit prüfen

Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial

Annals of internal medicine, 2010-07, Vol.153 (1), p.8

2010

Link zum Volltext

Verfügbarkeit prüfen

Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: methodology for the EXCLAIM study

Journal of thrombosis and thrombolysis, 2006-08, Vol.22 (1), p.31-38

2006

Link zum Volltext

Verfügbarkeit prüfen

Use of Low-Molecular-Weight Heparins and New Anticoagulants in Elderly Patients with Renal Impairment

Drugs & aging, 2011-03, Vol.28 (3), p.177-193

Samama, Meyer Michel

2011

Link zum Volltext

Verfügbarkeit prüfen

Life-threatening bleeding in four patients with an unusual excessive response to dabigatran: implications for emergency surgery and resuscitation

Thrombosis and haemostasis, 2012-09, Vol.108 (3), p.583

2012

Link zum Volltext

Verfügbarkeit prüfen

In vitro study of the anticoagulant effects of edoxaban and its effect on thrombin generation in comparison to fondaparinux

Thrombosis research, 2012-04, Vol.129 (4), p.e77-e82

2012

Link zum Volltext

Verfügbarkeit prüfen

Do new oral anticoagulants require laboratory monitoring? The clinician point of view

Thrombosis research, 2012-10, Vol.130, p.S88-S89

2012

Link zum Volltext

Verfügbarkeit prüfen

Pharmacology and laboratory testing of the oral Xa inhibitors

Clinics in laboratory medicine, 2014-09, Vol.34 (3), p.503

2014

Link zum Volltext

Verfügbarkeit prüfen

Pregnancy‐associated venous thromboembolism (VTE) in combined heterozygous factor V Leiden (FVL) and prothrombin (FII) 20210 A mutation and in heterozygous FII single gene mutation alone

British journal of haematology, 2003-10, Vol.123 (2), p.327-334

2003

Link zum Volltext

Verfügbarkeit prüfen

Correlation of plasma coagulation parameters with thromboprophylaxis, patient characteristics, and outcome in the MEDENOX study

Archives of pathology & laboratory medicine (1976), 2004-05, Vol.128 (5), p.519-526

2004

Link zum Volltext

Verfügbarkeit prüfen

Venous Thromboembolism Risk in Ischemic Stroke Patients Receiving Extended-Duration Enoxaparin Prophylaxis: Results From the EXCLAIM Study

Stroke (1970), 2013, Vol.44 (1), p.249-251

2013

Link zum Volltext

Verfügbarkeit prüfen

Impact of age on the efficacy and safety of extended-duration thromboprophylaxis in medical patients. Subgroup analysis from the EXCLAIM randomised trial

Thrombosis and haemostasis, 2013-12, Vol.110 (6), p.1152

2013

Link zum Volltext

Verfügbarkeit prüfen

An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study

Archives of internal medicine (1960), 2000-12, Vol.160 (22), p.3415

Samama, M M

2000

Link zum Volltext

Verfügbarkeit prüfen

New Antithrombotic Drugs

Chest, 2012-02, Vol.141 (2), p.e120S-e151S

2012

Link zum Volltext

Verfügbarkeit prüfen

Occurrence of thrombosis and haemorrhage, relationship with anti‐Xa, anti‐IIa activities, and D‐dimer plasma levels in patients receiving a low molecular weight heparin, enoxaparin or tinzaparin, to prevent deep vein thrombosis after hip surgery

British journal of haematology, 1999-02, Vol.104 (2), p.230-240

1999

Link zum Volltext

Verfügbarkeit prüfen

Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Chest, 2012-02, Vol.141 (2 Suppl), p.e24S-e43S

2012

Link zum Volltext

Verfügbarkeit prüfen

Parenteral Anticoagulants

Chest, 2012-02, Vol.141 (2), p.e24S-e43S

2012

Link zum Volltext

Verfügbarkeit prüfen

An electronic tool for venous thromboembolism prevention in medical and surgical patients

Haematologica (Roma), 2006-01, Vol.91 (1), p.64-70

2006

Link zum Volltext

Verfügbarkeit prüfen

New antithrombotic drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Chest, 2012-02, Vol.141 (2 Suppl), p.e120S-e151S

2012

Link zum Volltext

Verfügbarkeit prüfen

Danqi Piantan Jiaonang Does Not Modify Hemostasis, Hematology, and Biochemistry in Normal Subjects and Stroke Patients

Cerebrovascular diseases (Basel, Switzerland), 2008-05, Vol.25 (5), p.450-456

2008

Link zum Volltext

Verfügbarkeit prüfen

Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis

Stroke (1970), 1996-10, Vol.27 (10), p.1724-1730

1996

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 146

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(124)
Mit Volltextzugriff
(111)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(78)
Humans
(77)
Life Sciences & Biomedicine
(77)
Biological And Medical Sciences
(50)
Hematology
(50)
Medical Sciences
(50)
Cardiovascular System & Cardiology
(34)
Peripheral Vascular Disease
(33)
Female
(27)
Male
(27)
Pharmacology. Drug Treatments
(24)
Aged
(23)
Middle Aged
(22)
Anticoagulants - Therapeutic Use
(21)
Hematologic And Hematopoietic Diseases
(20)
Adult
(18)
Blood. Blood Coagulation. Reticuloendothelial System
(18)
Factor Xa Inhibitors
(18)
Anticoagulants
(17)
Platelet Diseases And Coagulopathies
(16)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality

The mechanism of action of rivaroxaban – an oral, direct Factor Xa inhibitor – compared with other anticoagulants

Evaluation of the pharmacological properties and clinical results of the synthetic pentasaccharide (fondaparinux)

Monitoring plasma levels of factor Xa inhibitors: how, why and when?

Assessment of laboratory assays to measure rivaroxaban--an oral, direct factor Xa inhibitor

Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial

Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: methodology for the EXCLAIM study

Use of Low-Molecular-Weight Heparins and New Anticoagulants in Elderly Patients with Renal Impairment

Life-threatening bleeding in four patients with an unusual excessive response to dabigatran: implications for emergency surgery and resuscitation

In vitro study of the anticoagulant effects of edoxaban and its effect on thrombin generation in comparison to fondaparinux

Do new oral anticoagulants require laboratory monitoring? The clinician point of view

Pharmacology and laboratory testing of the oral Xa inhibitors

Pregnancy‐associated venous thromboembolism (VTE) in combined heterozygous factor V Leiden (FVL) and prothrombin (FII) 20210 A mutation and in heterozygous FII single gene mutation alone

Correlation of plasma coagulation parameters with thromboprophylaxis, patient characteristics, and outcome in the MEDENOX study

Venous Thromboembolism Risk in Ischemic Stroke Patients Receiving Extended-Duration Enoxaparin Prophylaxis: Results From the EXCLAIM Study

Impact of age on the efficacy and safety of extended-duration thromboprophylaxis in medical patients. Subgroup analysis from the EXCLAIM randomised trial

An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study

New Antithrombotic Drugs

Occurrence of thrombosis and haemorrhage, relationship with anti‐Xa, anti‐IIa activities, and D‐dimer plasma levels in patients receiving a low molecular weight heparin, enoxaparin or tinzaparin, to prevent deep vein thrombosis after hip surgery

Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Parenteral Anticoagulants

An electronic tool for venous thromboembolism prevention in medical and surgical patients

New antithrombotic drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Danqi Piantan Jiaonang Does Not Modify Hemostasis, Hematology, and Biochemistry in Normal Subjects and Stroke Patients

Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis

Suchergebnisse filtern